JNJ · News · 20261101N

Shockwave Javelin Trial Results

JOHNSON & JOHNSON · 2026-11-01 · Importance 31 · Surprise 42

Johnson & Johnson reported 30-day results from the FORWARD CAD study of its experimental Shockwave Javelin catheter for severely narrowed coronary arteries that are difficult to access with conventional devices. The study enrolled 158 patients with hardened calcium deposits obstructing coronary arteries. The catheter achieved 93.6% technical success, while 93.4% of patients remained free of major cardiovascular events at 30 days; serious imaging-detected complications occurred in 1.3%.

Key facts

• Johnson & Johnson reported positive 30-day results from a clinical trial of its experimental Shockwave Javelin catheter, designed to treat severely narrowed coronary arteries that are difficult to access with conventional devices. source
• The FORWARD CAD study of Johnson & Johnson's Shockwave Javelin catheter enrolled 158 patients with hardened calcium deposits obstructing arteries that supply blood to the heart. source
• The Shockwave Javelin catheter achieved a 93.6% technical success rate in the FORWARD CAD study. source
• At 30 days in the FORWARD CAD study, 93.4% of patients remained free from major cardiovascular events, including heart-related death, heart attack, or procedures to restore blood flow in the treated artery. source
• Serious complications detected through imaging occurred in 1.3% of patients in the FORWARD CAD study. source